1
|
Lou Y, Ma Y, Suo S, Ni W, Wang Y, Pan H, Tong H, Qian W, Meng H, Mai W, Huang J, Yu W, Wei J, Mao L, Jin J. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy. Leuk Res 2015; 39:938-44. [PMID: 26183877 DOI: 10.1016/j.leukres.2015.05.016] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2015] [Revised: 05/15/2015] [Accepted: 05/16/2015] [Indexed: 12/11/2022]
Abstract
Prognostic factors for patients with acute promyelocytic leukemia (APL) treated in the context of arsenic trioxide (ATO)-based frontline regimes have not been established clearly. We retrospectively analyzed the clinical features, immunophenotypes, Fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD), and outcomes of 184 consecutive newly diagnosed APL patients treated by intravenous ATO-based therapy. The median age was 40 years (14-77 years). The early death rate was 4.9% (9/184 patients). With a median follow-up time of 36 months (9-74 months), the 3-year relapse-free survival (RFS) and overall survival (OS) were 93.3% and 92.2%, respectively. Interestingly, there was no meaningful association between 3-year RFS and initial white blood cell count, FLT3-ITD status, or type of PML-RARA isoforms. In multivariable analysis, the CD56 expression was the only independent risk factor in terms of RFS (hazard ratio, 4.70; P=0.005). These results suggested that ATO-based therapy may ameliorate the unfavorable influence of previously known high-risk features; moreover, CD56 expression remains to be a potentially unfavorable prognostic factor in APL patients.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Arsenic Trioxide
- Arsenicals/therapeutic use
- Biomarkers, Tumor/genetics
- CD56 Antigen/genetics
- Chromosome Duplication
- Female
- Gene Expression
- Humans
- Injections, Intravenous
- Leukemia, Promyelocytic, Acute/diagnosis
- Leukemia, Promyelocytic, Acute/drug therapy
- Leukemia, Promyelocytic, Acute/genetics
- Leukemia, Promyelocytic, Acute/mortality
- Male
- Middle Aged
- Multivariate Analysis
- Oncogene Proteins, Fusion/genetics
- Oxides/therapeutic use
- Prognosis
- Retrospective Studies
- Risk Factors
- Survival Analysis
- fms-Like Tyrosine Kinase 3/genetics
Collapse
Affiliation(s)
- Yinjun Lou
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Yafang Ma
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Shanshan Suo
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Wanmao Ni
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Yungui Wang
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Hanzhang Pan
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Hongyan Tong
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Wenbin Qian
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Haitao Meng
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Wenyuan Mai
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Jian Huang
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Wenjuan Yu
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Juyin Wei
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Liping Mao
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
| | - Jie Jin
- Department of Hematology, Institute of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, China.
| |
Collapse
|
2
|
Saviano M, Romanelli A, Bucci E, Pedone C, Mischiati C, Bianchi N, Feriotto G, Borgatti M, Gambari R. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites. J Biomol Struct Dyn 2000; 18:353-62. [PMID: 11149512 DOI: 10.1080/07391102.2000.10506672] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Peptide nucleic acids (PNA) have recently been proposed as alternative reagents in experiments aimed to the control of gene expression. In PNAs, the pseudopeptide backbone is composed of N-(2-aminoethyl)glycine units and therefore is stable in human serum and cellular extracts. PNAs hybridize with high affinity to complementary sequences of single-stranded RNA and DNA, forming Watson-Crick double helices and giving rise to highly stable (PNA)2-RNA triplexes with RNA targets. Therefore, antisense and antigene PNAs have been synthetized and characterized. The major issue of the present paper is to describe some computational procedures useful to compare the behaviour of PNA double stranded molecules and PNA/DNA hybrids with the behaviour of regular DNA duplexes in generating complexes with DNA-binding proteins. The performed computational analyses clearly allow to predict that the lack of charged phosphate groups and the different shape of helix play a critical role in the binding efficiency of NF-kappaB transcription factors. These computational analyses are in agreement with competitive gel shift and UV-cross linking experiments. These experiments demonstrate that NF-kappaB PNA/PNA hybrids do not interact efficiently with proteins recognizing the NF-kappaB binding sites in genomic sequences. In addition, the data obtained indicate that the same NF-kappaB binding proteins recognize both the NF-kappaB DNA/PNA and DNA/DNA hybrids, but the molecular complexes generated with NF-kappaB DNA/PNA hybrids are less stable than those generated with NF-kappaB target DNA/DNA molecules.
Collapse
Affiliation(s)
- M Saviano
- Biocrystallography Research Centre, CNR, Napoli, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Penolazzi L, Lambertini E, Aguiari G, del Senno L, Piva R. Modulation of estrogen receptor gene expression in human breast cancer cells: a decoy strategy with specific PCR-generated DNA fragments. Breast Cancer Res Treat 1998; 49:227-35. [PMID: 9776506 DOI: 10.1023/a:1006060523381] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Transcriptional activity of human estrogen receptor (hER) gene was modulated by competition with double-stranded PCR-generated DNA fragments (decoys) that contain 5' upstream sequences of the hER gene. Two DNA fragments belonging to the P1 canonical promoter and the P3 distal promoter, 120 and 102 bp in size respectively, were produced by PCR and directly transfected in MCF7 breast cancer cells. After 24 hours transfection, RT-PCR analysis revealed that the 120 bp decoy significantly reduced the expression of the ER gene and estrogen responsive genes (PR and c-myc), whereas the 102 bp decoy increased the ER mRNA level. An ER unrelated PCR product, used as control, had no activity. The biological activity of these ds DNAs was related to their high stability, binding affinities, and lack of cytotoxicity. These findings suggest that such PCR product decoys may be a non-antisense tool to analyze putative regulatory sequences and to study the function of DNA-binding transcription factors.
Collapse
Affiliation(s)
- L Penolazzi
- Dipartimento di Biochimica e Biologia Molecolare, Università degli Studi di Ferrara, Italy
| | | | | | | | | |
Collapse
|
4
|
Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C, Gambari R. Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor.DNA complexes and inhibition of in vitro transcription. Biochem Pharmacol 1996; 52:1489-98. [PMID: 8937462 DOI: 10.1016/s0006-2952(96)00510-2] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Sequence selectivity of DNA-binding drugs has recently been reported in a number of studies employing footprinting and gel retardation approaches. In this paper, we studied the biochemical effects of the sequence-selective binding of chromomycin to the long terminal repeat of the human immunodeficiency type I virus. Deoxyribonuclease I (E.C.3.1.21.1) footprinting, arrested polymerase chain reaction, gel retardation and in vitro transcription experiments have demonstrated that chromomycin preferentially interacts with the binding sites of the promoter-specific transcription factor Sp1. Accordingly, interactions between nuclear proteins and Sp1 binding sites are inhibited by chromomycin, and this effect leads to a sharp inhibition of in vitro transcription.
Collapse
Affiliation(s)
- N Bianchi
- Biotechnology Centre, Ferrara University, Italy
| | | | | | | | | | | |
Collapse
|
5
|
Feriotto G, Mischiati C, Bianchi N, Rutigliano C, Giacomini P, Gambari R. Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes. Nucleic Acids Res 1995; 23:1671-8. [PMID: 7784170 PMCID: PMC306920 DOI: 10.1093/nar/23.10.1671] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
In this paper we report the characterization of a newly sequenced 5' upstream region of the human HLA-DRA gene. We performed (i) search for transcription factor motifs, (ii) analysis of CpG display and observed/expected frequency ratios, (iii) search for regions homologous to the 5' upstream sequences of the murine EA gene, (iv) DNase I footprinting experiments and (v) electrophoretic mobility shift assays. Our results demonstrate the existence, in the HLA-DRA gene, of Y' and X' boxes highly homologous to the Y and X boxes present in MHC class II genes, but oriented in the opposite direction. These Y' and X' boxes have been conserved during the molecular evolution of both human HLA-DRA and murine EA genes. DNase I footprinting and gel retardation experiments suggest that the X' and Y' boxes of the HLA-DRA upstream gene region are specifically recognized by nuclear proteins that also bind to the X and Y boxes of the HLA-DRA proximal promoter, respectively.
Collapse
Affiliation(s)
- G Feriotto
- Centro Interdipartimentale di Biotecnologie, Università di Ferrara, Italy
| | | | | | | | | | | |
Collapse
|
6
|
Ciucci A, Feriotto G, Mischiati C, Gambari R, Animati F, Lombardi P, Natali PG, Arcamone F, Giacomini P. Distamycin analogues with improved sequence-specific DNA binding activities. Biochem Pharmacol 1994; 48:1583-91. [PMID: 7980624 DOI: 10.1016/0006-2952(94)90203-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
In the present study we have investigated the effect of unprecedented chemical modifications introduced in the distamycin molecule, with the aim of assessing their ability to interfere with sequence-specific DNA-protein interactions in vitro. By using an electrophoretic mobility shift assay, we have been able to identify novel distamycin analogues with improved displacing abilities on the binding of octamer nuclear factors to their target DNA sequence. While variations in the number of pyrrole rings and/or reversion of an internal amide bond result in distamycin-like compounds with identical or very similar properties, the reversion of the formamido into a carboxyamido group or its replacement with the charged formimidoyl moiety significantly improves the ability of the resulting novel distamycin derivatives to compete with OCT-1 (octamer 1 nuclear factor) for its target DNA sequence. Tissue-specific octamer-dependent in vitro transcription is similarly affected by these chemical modifications, suggesting that the ability of distamycins to bind octamer sequences has a direct influence on the functional state of octamer-containing promoters. These data represent an initial, successful attempt to rationalize the design of DNA binding drugs, using distamycins as a model.
Collapse
Affiliation(s)
- A Ciucci
- Menarini Ricerche Sud, Pomezia, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Feriotto G, Ciucci A, Mischiati C, Animati F, Lombardi P, Giacomini P, Arcamone F, Gambari R. Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues. Eur J Pharmacol 1994; 267:143-9. [PMID: 8050475 DOI: 10.1016/0922-4106(94)90165-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Modulation of the interaction between cellular or viral transcription factors and target DNA sequences may represent a potential experimental strategy to control proliferation of neoplastic cells as well as virus DNA replication. Distamycin represents a likely candidate to mediate such modulation by pharmacological means. In order to obtain more detailed information on structure-activity relationships of these compounds, we have analysed the effects of distamycin and two distamycin analogues on the binding of a recombinant protein, the Epstein-Barr virus nuclear antigen 1 (EBNA-1) to its target sequence of Epstein-Barr virus, containing the 12 bp palindromic consensus TAGCATATGCTA. The sequence selectivity in the binding of distamycin to DNA was evaluated by footprinting experiments, while the effects of distamycins on DNA-protein interactions was analysed by means of electrophoretic mobility shift assay. The data presented in this paper suggest that distamycin and its analogues differentially inhibit the interaction between DNA-binding proteins and target DNA sequences.
Collapse
Affiliation(s)
- G Feriotto
- Istituto di Chimica Biologica, Università di Ferrara, Italy
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Feriotto G, Mischiati C, Gambari R. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study. Biochem J 1994; 299 ( Pt 2):451-8. [PMID: 8172606 PMCID: PMC1138293 DOI: 10.1042/bj2990451] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Pharmacological modulation of the interaction between transcription factors and target DNA sequences of cellular and viral genes could have important effects in the experimental therapy of a large variety of human pathologies. For instance, alteration of the DNA/protein interaction might be among the molecular mechanisms of action of DNA-binding drugs, leading to an inhibition of the expression of genes involved in the control of in vitro and in vivo growth of neoplastic cells and virus DNA replication. Natural oligopeptides, such as distamycin, are powerful inhibitors of the interaction between nuclear factors and target DNA sequences and, therefore, have been proposed as compounds retaining antibiotic, antineoplastic and antiviral properties. In this study we performed DNAase I footprinting analysis using a PCR product mimicking a region of the long terminal repeat (LTR) of the human immunodeficiency type 1 (HIV-1) retrovirus. The data obtained suggest that distamycin binds to different regions of the HIV-1 LTR depending on the DNA sequence. Electrophoretic mobility shift assays using both crude nuclear extracts from the Jurkat T-lymphoid cell line and the recombinant proteins transcription factor IID and Sp1 suggest that distamycin differentially inhibits the interaction of these two proteins with their specific DNA target sequences, in good agreement with the results obtained by DNAase I footprinting analysis.
Collapse
Affiliation(s)
- G Feriotto
- Biochemistry Institute, Ferrara University, Italy
| | | | | |
Collapse
|
9
|
Gambari R, Nastruzzi C. DNA-binding activity and biological effects of aromatic polyamidines. Biochem Pharmacol 1994; 47:599-610. [PMID: 8129738 DOI: 10.1016/0006-2952(94)90121-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- R Gambari
- Biotechnology Center, University of Ferrara, Italy
| | | |
Collapse
|
10
|
Affiliation(s)
- C Nastruzzi
- Department of Pharmaceutical Sciences, University of Ferrara, Italy
| | | | | |
Collapse
|
11
|
Gambari R, Chiorboli V, Feriotto G, Nastruzzi C. TAPP (tetra-p-amidinophenoxyneopentane) inhibits the binding of nuclear factors to target DNA sequences. Int J Pharm 1991. [DOI: 10.1016/0378-5173(91)90115-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Gambari R, Barbieri R, Nastruzzi C, Chiorboli V, Feriotto G, Natali PG, Giacomini P, Arcamone F. Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DR alpha gene. Biochem Pharmacol 1991; 41:497-502. [PMID: 1997000 DOI: 10.1016/0006-2952(91)90620-k] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
In this study we analyse the effects of the anti-tumor compound distamycin on the binding of nuclear factor(s) to a synthetic oligonucleotide (GTATA/IFN-gamma) mimicking a putative regulatory region of the human HLA-DR alpha gene. This region contains the sequence (GTATA), that is required for nuclear protein binding and is likely to interact with distamycin. The present results, by showing that distamycin inhibits the interaction between nuclear factors and the GTATA/IFN-gamma oligonucleotide, suggest that distamycin might alter the binding of transacting factors to cis-elements containing AT/TA sequences. Alterations of nuclear protein binding to specific target sequences could be one of the molecular mechanism(s) by which distamycin exerts its antiproliferative activity on living cells.
Collapse
Affiliation(s)
- R Gambari
- Istituto di Chimica Biologica, Università di Ferrara, Italy
| | | | | | | | | | | | | | | |
Collapse
|